NYVBX
Price
$17.83
Change
+$0.32 (+1.83%)
Updated
Apr 23 closing price
Net Assets
5.9B
VFINX
Price
$506.43
Change
+$10.05 (+2.02%)
Updated
Apr 24 closing price
Net Assets
1.32T
Ad is loading...

NYVBX vs VFINX

Header iconNYVBX vs VFINX Comparison
Open Charts NYVBX vs VFINXBanner chart's image
Davis NY Venture B
Price$17.83
Change+$0.32 (+1.83%)
VolumeN/A
Net Assets5.9B
Vanguard 500 Index Investor
Price$506.43
Change+$10.05 (+2.02%)
VolumeN/A
Net Assets1.32T
NYVBX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NYVBX vs. VFINX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NYVBX is a Buy and VFINX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.32T vs. NYVBX (5.9B). VFINX pays higher dividends than NYVBX: VFINX (1.24) vs NYVBX (0.74). NYVBX was incepted earlier than VFINX: NYVBX (30 years) vs VFINX (49 years). NYVBX (2.37) is less costly to investors than VFINX (0.14). NYVBX is a more actively managed with annual turnover of: 17.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than NYVBX: VFINX (0) vs NYVBX (1000). VFINX annual gain was more profitable for investors over the last year : 4.33 vs. NYVBX (-20.83). VFINX return over 5 years is better than : 86.46 vs. NYVBX (-10.12).
NYVBXVFINXNYVBX / VFINX
Total Expense Ratio1.750.141,250%
Annual Report Gross Expense Ratio2.370.141,693%
Fund Existence30 years49 years-
Gain YTD-4.369-10.04843%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.9B1.32T0%
Annual Yield % from dividends0.741.2459%
Returns for 1 year-20.834.33-482%
Returns for 3 years-11.5023.87-48%
Returns for 5 years-10.1286.46-12%
Returns for 10 years-50.40150.13-34%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGLS2.550.23
+9.70%
Regulus Therapeutics
BOOT96.863.54
+3.79%
Boot Barn Holdings
IMNM8.480.29
+3.54%
Immunome
RS283.113.02
+1.08%
Reliance
EVGN1.09-0.03
-2.68%
Evogene Ltd.